Klebsiella pneumoniae with carbapenemases : high prevalence of sequence type 307 with blaOXA181 in South African community hospitals

Show simple item record

dc.contributor.author Salvador-Oke, Kafilat Taiwo
dc.contributor.author Pitout, Johann D.D.
dc.contributor.author Peirano, Gisele
dc.contributor.author Strydom, Kathy-Anne
dc.contributor.author Kingsburgh, Chanel
dc.contributor.author Ehlers, Marthie Magdaleen
dc.contributor.author Kock, Marleen M.
dc.date.accessioned 2024-10-22T06:34:07Z
dc.date.available 2024-10-22T06:34:07Z
dc.date.issued 2024-09
dc.description DATA AVAILABILITY : No datasets were generated or analysed during the current study. en_US
dc.description.abstract This study investigated the molecular characteristics of urinary carbapenemase-producing Klebsiella pneumoniae isolates (n = 194) in Gauteng, South Africa, using simple, cost-effective PCR methodologies. Extensively drug resistant (XDR) ST307 with blaOXA-181 on IncX3 plasmids was endemic in Gauteng community hospitals leaving limited options for treating in- and outpatient urinary tract infections. High-level ceftazidime/avibactam resistance was detected among isolates harbouring blaOXA-48-like including blaOXA-181. These findings highlighted the need for genomic methodologies suitable for lower- and middle-income countries to track XDR clones and plasmids in community hospitals. Such results will aid with treatment and stewardship strategies. en_US
dc.description.department Medical Microbiology en_US
dc.description.librarian hj2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship The National Research Foundation (NRF) of South Africa; Competitive Support for Unrated Researchers and the University of Pretoria (PhD student bursary, 2022). Open access funding provided by University of Pretoria. en_US
dc.description.uri https://link.springer.com/journal/10096 en_US
dc.identifier.citation Salvador-Oke, K.T., Pitout, J.D.D., Peirano, G. et al. Klebsiella pneumoniae with carbapenemases: high prevalence of sequence type 307 with blaOXA181 in South African community hospitals. European Journal of Clinical Microbiology & Infectious Diseases (2024). https://doi.org/10.1007/s10096-024-04947-z. en_US
dc.identifier.issn 0934-9723 (print)
dc.identifier.issn 1435-4373 (online)
dc.identifier.other 10.1007/s10096-024-04947-z
dc.identifier.uri http://hdl.handle.net/2263/98695
dc.language.iso en en_US
dc.publisher Springer en_US
dc.rights © The Author(s) 2024. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License. en_US
dc.subject Klebsiella pneumoniae en_US
dc.subject Gauteng Province, South Africa en_US
dc.subject Extensively drug resistant (XDR) en_US
dc.subject Carbapenemase-producing Klebsiella pneumoniae en_US
dc.subject High-risk clone ST307 en_US
dc.subject IncX3 plasmid en_US
dc.subject bla OXA-181 en_US
dc.subject Low- and middle-income countries (LMICs) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Klebsiella pneumoniae with carbapenemases : high prevalence of sequence type 307 with blaOXA181 in South African community hospitals en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record